Standard BioTools EBITDA 2010-2025 | LAB
Standard BioTools ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Standard BioTools Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-166 |
| 2023 | $-63 |
| 2022 | $-102 |
| 2021 | $-51 |
| 2020 | $-33 |
| 2019 | $-34 |
| 2018 | $-23 |
| 2017 | $-39 |
| 2016 | $-55 |
| 2015 | $-34 |
| 2014 | $-38 |
| 2013 | $-16 |
| 2012 | $-16 |
| 2011 | $-17 |
| 2010 | $-13 |
| 2009 | $-16 |
| Standard BioTools Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-30 |
| 2024-12-31 | $-30 |
| 2024-09-30 | $-30 |
| 2024-06-30 | $-49 |
| 2024-03-31 | $-58 |
| 2023-12-31 | $-18 |
| 2023-09-30 | $-17 |
| 2023-06-30 | $-14 |
| 2023-03-31 | $-13 |
| 2022-12-31 | $-19 |
| 2022-09-30 | $-25 |
| 2022-06-30 | $-35 |
| 2022-03-31 | $-23 |
| 2021-12-31 | $-7 |
| 2021-09-30 | $-16 |
| 2021-06-30 | $-13 |
| 2021-03-31 | $-15 |
| 2020-12-31 | $-13 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-10 |
| 2019-12-31 | $-5 |
| 2019-09-30 | $-10 |
| 2019-06-30 | $-11 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $-4 |
| 2018-09-30 | $-5 |
| 2018-06-30 | $-6 |
| 2018-03-31 | $-7 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-11 |
| 2017-06-30 | $-12 |
| 2017-03-31 | $-13 |
| 2016-12-31 | $-13 |
| 2016-09-30 | $-14 |
| 2016-06-30 | $-14 |
| 2016-03-31 | $-15 |
| 2015-12-31 | $-10 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-10 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $-6 |
| 2014-09-30 | $-9 |
| 2014-06-30 | $-9 |
| 2014-03-31 | $-14 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-4 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-4 |
| 2012-03-31 | $-6 |
| 2011-12-31 | $-2 |
| 2011-09-30 | $-4 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-5 |
| 2010-12-31 | $-2 |
| 2010-09-30 | $-3 |
| 2010-06-30 | $-4 |
| 2010-03-31 | $-5 |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.424B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.971B | 53.83 |
| Hims & Hers Health (HIMS) | United States | $11.505B | 119.54 |
| Tempus AI (TEM) | United States | $11.232B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.506B | 70.41 |
| IRhythm Technologies (IRTC) | United States | $4.374B | 0.00 |
| Privia Health (PRVA) | United States | $3.041B | 208.92 |
| Clover Health Investments (CLOV) | United States | $1.916B | 0.00 |
| Enovis (ENOV) | United States | $1.889B | 10.53 |
| Schrodinger (SDGR) | United States | $1.744B | 0.00 |
| Phreesia (PHR) | United States | $1.492B | 0.00 |
| Azenta (AZTA) | United States | $1.266B | 58.96 |
| Omnicell (OMCL) | United States | $1.189B | 20.98 |
| 10x Genomics (TXG) | United States | $1.055B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.565B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| TruBridge (TBRG) | United States | $0.374B | 833.33 |
| Claritev (CTEV) | United States | $0.350B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.293B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.211B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| Pulmonx (LUNG) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.086B | 0.00 |
| CareCloud (CCLD) | United States | $0.078B | 2.97 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |